Both in Pharmaceuticals
Amarin vs Bicycle Therapeutics
Over the past year AMRN returned −18.3% and BCYC returned −52.0%; their daily moves had a correlation of 0.18.
AMRN −18.3% BCYC −52.0%Growth of $1, one year, split-adjusted
| Metric | AMRN | BCYC |
|---|---|---|
| Price | $13.14 | $3.65 |
| Market cap | $277.6M | $255.5M |
| Today | −0.83% | −1.62% |
| 1 month | −5.9% | −13.1% |
| 6 months | −5.8% | −15.9% |
| Year to date | −5.8% | −48.4% |
| 1 year | −17.9% | −50.7% |
| Revenue growth (YoY) | −42.0% | −78.5% |
| Gross margin | 35.5% | 100.0% |
| Net margin | −18.1% | −8002.1% |
| P/E (TTM) | — | — |
| Price / sales | 1.5× | 4.2× |
| Net cash | $314.6M | $510.1M |
| Dividend yield | — | — |
| Volatility (60d) | 23.0% | 40.1% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).